Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • PROMYCIN ® - Head and Neck Neoplasms
    Clinical Study Number 1164.3
    Study Indication Head and Neck Neoplasms
    Product PROMYCIN ®
    Generic Name Porfiromycin
    Lab Code
    Clinical Phase I
    Study Title

    A Phase I Intensive Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients with Solid Tumors who Receive Radiation Therapy

    Study Document
    Trial synopsis 1164.3_CO english
  • PROMYCIN ® - Head and Neck Neoplasms
    Clinical Study Number 1164.4
    Study Indication Head and Neck Neoplasms
    Product PROMYCIN ®
    Generic Name Porfiromycin
    Lab Code
    Clinical Phase III
    Study Title

    A Phase III, Double-Blind, Randomized, Placebo-Controlled Study of Porfrromycin used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients

    Study Document
    Trial synopsis 1164.4 english